← Back to Clinical Trials
Recruiting NCT06006962

NCT06006962 Aging Well Through Interactions and Scientific Education - Action Plan (AgeWISE-AP)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06006962
Status Recruiting
Phase
Sponsor VA Office of Research and Development
Condition Cognitive Aging
Study Type INTERVENTIONAL
Enrollment 128 participants
Start Date 2024-01-01
Primary Completion 2026-05-31

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Aging Well through Interactions and Scientific Education - Action Plan

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 128 participants in total. It began in 2024-01-01 with a primary completion date of 2026-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to learn about the effects of AgeWISE-Action Plan (AgeWISE-AP), a 20-week program designed to provide education and individualized planning with a goal of improving brain health.

Eligibility Criteria

Inclusion Criteria: * Veterans \> 60 years old with concerns about brain aging who want to learn more about cognitive aging * English speaking as all intervention materials are written in English Exclusion Criteria: * Veterans with impairment on a cognitive screening measure, as determined using a MoCA cutoff score for dementia of \<24 OR self or other reported diagnosis of a brain disorder affecting cognition such as Alzheimer's disease, Parkinson's disease, other dementia, major stroke, or brain injury or diagnosis of psychotic disorder such as schizophrenia * Active alcohol or substance abuse

Contact & Investigator

Central Contact

Andrew H Nguyen, MA

✉ andrew.nguyen@va.gov

📞 (781) 825-3123

Principal Investigator

Maureen O'Connor, PsyD

PRINCIPAL INVESTIGATOR

VA Bedford HealthCare System, Bedford, MA

Frequently Asked Questions

Who can join the NCT06006962 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Cognitive Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06006962 currently recruiting?

Yes, NCT06006962 is actively recruiting participants. Contact the research team at andrew.nguyen@va.gov for enrollment information.

Where is the NCT06006962 trial being conducted?

This trial is being conducted at Bedford, United States.

Who is sponsoring the NCT06006962 clinical trial?

NCT06006962 is sponsored by VA Office of Research and Development. The principal investigator is Maureen O'Connor, PsyD at VA Bedford HealthCare System, Bedford, MA. The trial plans to enroll 128 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology